Overview

Healthy Volunteer Study Comparing Tablet and Capsule Formulations

Status:
Withdrawn
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Single center, randomized, open label, two-part crossover study designed to evaluate the PK, food effect, dose proportionality, safety, and tolerability of BLD-2660 in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Blade Therapeutics